Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial

Published:2019-04-22 Issue:5 Volume:15 Page:1139-1144
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Nakayama Tetsuo¹,Eda Masahiro²,Hirano Motonori²,Goto Wakako²

Affiliation:

1. Kitasato Institute for Life Sciences, Laboratory of Viral Infection, Tokyo, Japan

2. Japan Vaccine Co., Ltd, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1578591

Reference31 articles.

1. Mumps Vaccines

2. Vaccine chronicle in Japan

3. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan

4. A New Combined Trivalent Live Measles (AIK-C Strain), Mumps (Hoshino Strain), and Rubella (Takahashi Strain) Vaccine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing clinical benefits of live-attenuated vaccination in post-liver transplant patients: Analysis of breakthrough infections and natural boosters;American Journal of Transplantation;2024-07

2. Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5–6 years;Journal of Infection and Chemotherapy;2024-06

3. A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine;Human Vaccines & Immunotherapeutics;2024-01-18

4. Rubella Vaccines;Plotkin's Vaccines;2023

5. Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus;Journal of Immunological Methods;2021-03